by Biogen is a Biotechnology company, headquartered in Cambridge, Massachusetts. The company is listed on the Nasdaq with ticker name BIIB. Michel Vounatsos is heading the company as the chief executive officer since 6 Jan 2017. The company is engaged in the business of Plegridy, Spinraza and Avonex. They have more than 7,300 employees in 2017.
So, let’s see information on Biogen Board of Directors Compensation and Salary.
Biogen Board of Directors Compensation and Salary 2019
Alexander J. Denner – founding partner and Chief Investment Officer of Sarissa Capital Management LP
This board member is the founding partner and Chief Investment Officer of Sarissa Capital Management LP. This board member was paid total compensation US$422,643 including base salary (fees paid in cash) US$142,500, stock awards US$270,143 and all other compensation US$10,000.
Caroline D. Dorsa – Executive Vice President and Chief Financial Officer of Public Service Enterprise Group, Inc.
This board member is the Executive Vice President and Chief Financial Officer of Public Service Enterprise Group, Inc. This board member was paid total compensation US$416,643 including base salary (fees paid in cash) US$146,500, stock awards US$270,143 and all other compensation US$0.
William A. Hawkins – Senior Advisor to EW Healthcare Partners
This board member is the Senior Advisor to EW Healthcare Partners. This board member was paid total compensation US$330,036 including base salary (fees paid in cash) US$59,893, stock awards US$270,143 and all other compensation US$0.
Nancy L. Leaming – Chief Executive Officer and President of Tufts Health Plan
This board member is the Chief Executive Officer and President of Tufts Health Plan. This board member was paid total compensation US$421,333 including base salary (fees paid in cash) US$125,000, stock awards US$270,143 and all other compensation US$26,190.
Jesus B. Mantas – Senior Managing Partner for Global Strategy
This board member is the Senior Managing Partner for Global Strategy. This board member was paid total compensation US$333,286 including base salary (fees paid in cash) US$63,143, stock awards US$270,143 and all other compensation US$0.
Richard C. Mulligan – Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School
This board member is the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School. This board member was paid total compensation US$401,393 including base salary (fees paid in cash) US$131,250, stock awards US$270,143 and all other compensation US$0.
Robert W. Pangia – partner in Ivy Capital Partners, LLC
This board member is the partner in Ivy Capital Partners, LLC. This board member was paid total compensation US$497,095 including base salary (fees paid in cash) US$138,500, stock awards US$270,143, Change in Pension Value and Nonqualified Deferred Compensation EarningsUS$63,452 and all other compensation US$25,000.
Stelios Papadopoulos – Chairman of the Board of Directors of Exelixis, Inc.
This board member is the Chairman of the Board of Directors of Exelixis, Inc. This board member was paid total compensation US$725,310 including base salary (fees paid in cash) US$269,750, stock awards US$445,560 and all other compensation US$10,000.
Brian S. Posner – founder and Managing Partner of Point Rider Group, LLC
This board member is the founder and Managing Partner of Point Rider Group, LLC. This board member was paid total compensation US$444,643 including base salary (fees paid in cash) US$149,500, stock awards US$270,143 and all other compensation US$25,000.
Eric K. Rowinsky – President of RGenix, Inc.
This board member is the President of RGenix, Inc. This board member was paid total compensation US$411,143 including base salary (fees paid in cash) US$141,000, stock awards US$270,143 and all other compensation US$0.
Lynn Schenk
This board member was paid total compensation US$424,393 including base salary (fees paid in cash) US$129,250, stock awards US$270,143 and all other compensation US$25,000.
Stephen A. Sherwin – Chairman of Ceregene, Inc.
This board member is the Chairman of Ceregene, Inc. This board member was paid total compensation US$411,893 including base salary (fees paid in cash) US$116,750, stock awards US$270,143 and all other compensation US$25,000.
